Cargando…
Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort study
OBJECTIVE: To assess the association between use of sodium-glucose co-transporter 2 (SGLT2) inhibitors and risk of serious renal events in data from routine clinical practice. DESIGN: Cohort study using an active comparator, new user design and nationwide register data. SETTING: Sweden, Denmark, and...
Autores principales: | Pasternak, Björn, Wintzell, Viktor, Melbye, Mads, Eliasson, Björn, Svensson, Ann-Marie, Franzén, Stefan, Gudbjörnsdottir, Soffia, Hveem, Kristian, Jonasson, Christian, Svanström, Henrik, Ueda, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188014/ https://www.ncbi.nlm.nih.gov/pubmed/32349963 http://dx.doi.org/10.1136/bmj.m1186 |
Ejemplares similares
-
Use of sodium glucose cotransporter 2 inhibitors and risk of major cardiovascular events and heart failure: Scandinavian register based cohort study
por: Pasternak, Björn, et al.
Publicado: (2019) -
Use of incretin-based drugs and risk of cholangiocarcinoma: Scandinavian cohort study
por: Ueda, Peter, et al.
Publicado: (2021) -
Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study
por: Ueda, Peter, et al.
Publicado: (2018) -
Data Mining for Adverse Events of Tumor Necrosis Factor-Alpha Inhibitors in Pediatric Patients: Tree-Based Scan Statistic Analyses of Danish Nationwide Health Data
por: Wintzell, Viktor, et al.
Publicado: (2020) -
Oral fluoroquinolone use and serious arrhythmia: bi-national cohort study
por: Inghammar, Malin, et al.
Publicado: (2016)